Monte Rosa Therapeutics's total assets for Q3 2025 were $459.84M, an increase of 27.88% from the previous quarter. GLUE total liabilities were $214.00M for the fiscal quarter, a 133.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.